Loading company…
Curie Therapeutics develops radiopharmaceuticals designed to diagnose solid cancers and deliver radiation to tumors.
Curie Therapeutics develops radiopharmaceuticals that diagnose solid cancers and deliver radiation to disease sites. Its peptide-based drug candidates use alpha- and beta-emitting radionuclides and are designed for tumor distribution and systemic clearance. In September 2023, Mariana Oncology, Inc. raised USD 170 million in Series B funding co-led by Deep Track Capital and Forbion, with Eli Lilly & Company, Nextech, Surveyor Capital, Access Industries, Atlas Venture and RA Capital Management participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in